マーケットレポート詳細
アプタマーの世界市場：技術別、用途別2026年予測
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
- 出版元：MarketsandMarkets
出版元について - 発行年：2021年11月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文178ページになります。
- 商品コード：MAM2725
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
アプタマーの世界市場規模は2021年で1億5100万ドル、2026年には3億4000万ドルへと拡大し、市場の平均年成長率は17.7%で推移する見込みです。
アプタマー市場の成長要因としては、アプタマーベースの治療法開発のための臨床試験数の増加、抗体と比較したアプタマーの利点に関する認識の広がり、医薬品の研究開発への投資拡大、などが挙げられます。また慢性疾患や希少疾病の有病率の増加による、アプタマーベースの治療法/診断の需要増加なども成長要因となる可能性があります。一方、抗体と比較して市場での受け入れが低いことや、専門家の不足は成長障壁になる可能性があります。セグメント別市場では、技術別でSELEXが2020年のアプタマー市場で最大です。
レポートはアプタマーの世界市場について2026年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（タイプ別市場、技術別市場、等）を中心に構成されています。また競合状況、主要企業情報（20社）、COVID-19によるアプタマー市場への影響、ファイブフォース分析などの分析も加味し、アプタマー市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆アプタマーの世界市場予測2019-2026年
・市場規模(US$)
◆タイプ別、市場-2026年
・DNAアプタマー
・XNAアプタマー
・RNAアプタマー
※(市場規模US$)
◆技術別、市場-2026年
・SELEX
・その他技術
※(市場規模US$)
◆用途別、市場-2026年
・治療法の開発
・研究開発
・診断
・その他用途
※(市場規模US$)
◆エンドユーザー別、市場-2026年
・製薬/バイオテクノロジー企業
・アカデミック/政府系研究機関
・委託研究機関（CRO）
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2026年
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（ドライバー、障壁、機会、課題）
・COVID-19によるアプタマー市場への影響
・ファイブフォース分析
・バリューチェーン分析
・特許分析
・競合状況
◆アプタマーの主要企業プロフィール動向
・APTAMER GROUP
・RAPTAMER DISCOVERY GROUP
・SOMALOGIC, INC.
・APTAMER SCIENCES, INC.
・APTAGEN, LLC
・MARAVAI LIFESCIENCES
・株式会社カネカ
・NEOVENTURES BIOTECHNOLOGY INC.
・APTUS BIOTECH
・BASE PAIR BIOTECHNOLOGIES
・AMSBIO
・NOVAPTECH
・BIO-TECHNE
・APTITUDE MEDICAL SYSTEMS
・RAYBIOTECH, INC.
・ALPHA DIAGNOSTIC INTERNATIONAL, INC.
・CREATIVE BIOLABS
・CREATIVE BIOGENE
・VIVONICS INC.
・IBA LIFESCIENCES GMBH
（その他企業）
・APTABHARAT INNOVATIONS PVT. LTD
・PROFACGEN
・MEDIVEN
・PURE BIOLOGICS SA
・OAK BIOSCIENCES, INC.
（全178頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
・ FIGURE 1................................................. APTAMERS MARKET
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATION
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2.................................................. RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 3........... APTAMERS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
・ FIGURE 4..... MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF APTAMERS IN THE MARKET
・ FIGURE 5..................... AVERAGE MARKET SIZE ESTIMATION, 2020
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
・ FIGURE 6..... APTAMERS MARKET: CAGR PROJECTIONS, 2021–2026
・ FIGURE 7...... APTAMERS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ FIGURE 8..... MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 9.......................... DATA TRIANGULATION METHODOLOGY
2.5 INSIGHTS FROM PRIMARIES
・ FIGURE 10............. MARKET VALIDATION FROM PRIMARY EXPERTS
2.6 RESEARCH ASSUMPTIONS
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
2.7 RISK ANALYSIS
3.... EXECUTIVE SUMMARY
・ FIGURE 11........ APTAMERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
・ FIGURE 12.... APTAMERS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
・ FIGURE 13.... APTAMERS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
・ FIGURE 14. APTAMERS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
・ FIGURE 15........... GEOGRAPHICAL SNAPSHOT: APTAMERS MARKET
4.... PREMIUM INSIGHTS
4.1 APTAMERS MARKET OVERVIEW
・ FIGURE 16... INCREASING INVESTMENTS IN PHARMACEUTICAL R&D
TO SUPPORT MARKET GROWTH
4.2 NORTH AMERICA: APTAMERS MARKET SHARE, BY TYPE & COUNTRY (2020)
・ FIGURE 17 DNA APTAMERS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN APTAMERS MARKET IN 2020
4.3 APTAMERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
・ FIGURE 18.. XNA APTAMERS SEGMENT WILL DOMINATE THE MARKET IN 2026
4.4 APTAMERS MARKET SHARE, BY END USER, 2020
・ FIGURE 19....... PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.5 APTAMERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 20. ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH FROM 2021 TO 2026
5.... MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 21................ APTAMERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 1........................... APTAMERS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 RISING NUMBER OF CLINICAL TRIALS TO DEVELOP APTAMER-BASED THERAPEUTICS
・ TABLE 2..... LIST OF APTAMERS/APTAMER-BASED THERAPEUTICS IN PIPELINE
5.2.1.2 RISING AWARENESS OF THE ADVANTAGES OF APTAMERS OVER ANTIBODIES.. 52
5.2.1.3 INVESTMENTS IN PHARMACEUTICAL R&D
・ FIGURE 22 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
・ TABLE 3............ R&D SPENDING OF PROMINENT PHARMACEUTICAL COMPANIES IN 2019 & 2020 (USD BILLION
5.2.1.4 RISING PREVALENCE OF CHRONIC AND RARE DISEASES
・ FIGURE 23................... GLOBAL PREVALENCE OF CANCER, BY TYPE
5.2.2 RESTRAINTS
5.2.2.1 LOW MARKET ACCEPTANCE AS COMPARED TO ANTIBODIES
5.2.3 OPPORTUNITIES
5.2.3.1 GROWTH IN THE VENTURE CAPITAL FUNDING FOR RESEARCH ON APTAMERS
5.2.3.2 GROWING COLLABORATIONS WITH RESEARCH INSTITUTES AND PHARMACEUTICAL COMPANIES
5.2.4 CHALLENGES
5.2.4.1 SHORTAGE OF SKILLED & TRAINED PROFESSIONALS
5.3 IMPACT OF COVID-19 OUTBREAK ON THE APTAMERS MARKET
・ FIGURE 24........ APTAMERS MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-2021 (USD MILLION)
5.4 PIPELINE ANALYSIS
・ TABLE 4. THERAPEUTIC PIPELINE OF APTAMERS IN VARIOUS PHASES OF DRUG DEVELOPMENT
5.5 TECHNOLOGY ANALYSIS
5.6 PORTERS FIVE FORCES ANALYSIS
・ TABLE 5.................................. PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 ECOSYSTEM ANALYSIS
・ FIGURE 25................. APTAMERS MARKET: ECOSYSTEM ANALYSIS
5.8 VALUE CHAIN ANALYSIS
・ FIGURE 26............................. VALUE CHAIN: APTAMERS MARKET
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS
・ FIGURE 27................. PATENT PUBLICATION TRENDS: 2010–2021
5.9.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES)
FOR APTAMER PATENTS
・ TABLE 6... JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR APTAMER PATENTS
・ FIGURE 28........ JURISDICTION ANALYSIS FOR THE US (2014–2021)
6.... APTAMERS MARKET, BY TYPE
6.1 INTRODUCTION
・ TABLE 7... APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2 DNA APTAMERS
6.2.1 INCREASING USE OF DNA APTAMERS AND THEIR WIDE AVAILABILITY BOOSTS SEGMENT GROWTH
・ TABLE 8..... DNA APTAMERS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 9... NORTH AMERICA: DNA APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 10............. EUROPE: DNA APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 11...... ASIA PACIFIC: DNA APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
6.3 XNA APTAMERS
6.3.1 FOCUS ON DEVELOPING NEXT-GENERATION APTAMERS FOR SPECIFIC TARGETS TO BOOST SEGMENT GROWTH
・ TABLE 12.... XNA APTAMERS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 13.. NORTH AMERICA: XNA APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 14.... EUROPE: XNA APTAMERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 15....... ASIA PACIFIC: XNA APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
6.4 RNA APTAMERS
6.4.1 INCREASING RESEARCH ACTIVITIES FOR THE USE OF RNA APTAMERS BOOSTS SEGMENT GROWTH
・ TABLE 16... RNA APTAMERS MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 17.. NORTH AMERICA: RNA APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 18............. EUROPE: RNA APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 19...... ASIA PACIFIC: RNA APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
7.... APTAMERS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
・ TABLE 20.. APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
7.2 SELEX
7.2.1 SELEX IS THE MOST WIDELY USED TECHNOLOGY FOR APTAMERS SELECTION
・ TABLE 21..... SELEX TECHNOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 22.......... NORTH AMERICA: SELEX TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 23....... EUROPE: SELEX TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 24. ASIA PACIFIC: SELEX TECHNOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
7.3 OTHER TECHNOLOGIES
・ TABLE 25.. OTHER TECHNOLOGIES MARKET, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 26....... NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 27.... EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 28........... ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
8.... APTAMERS MARKET, BY APPLICATION
8.1 INTRODUCTION
・ TABLE 29.. APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
8.2 THERAPEUTICS DEVELOPMENT
8.2.1 PROMINENT PLAYERS OFFERING SERVICES FOR THERAPEUTICS DEVELOPMENT TO BOOST THE MARKET GROWTH
・ TABLE 30 APTAMERS MARKET FOR THERAPEUTICS DEVELOPMENT, BY REGION,
2019–2026 (USD MILLION)
・ TABLE 31 NORTH AMERICA: APTAMERS MARKET FOR THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 32........... EUROPE: APTAMERS MARKET FOR THERAPEUTICS DEVELOPMENT,
BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 33..... ASIA PACIFIC: APTAMERS MARKET FOR THERAPEUTICS DEVELOPMENT,
BY COUNTRY, 2019–2026 (USD MILLION)
8.3 RESEARCH & DEVELOPMENT
8.3.1 INCREASING AVAILABILITY OF APTAMERS FOR ACADEMIC RESEARCH TO DRIVE MARKET GROWTH
・ TABLE 34.. APTAMERS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION,
2019–2026 (USD MILLION)
・ TABLE 35... NORTH AMERICA: APTAMERS MARKET FOR RESEARCH & DEVELOPMENT,
BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 36.............. EUROPE: APTAMERS MARKET FOR RESEARCH & DEVELOPMENT,
BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 37........ ASIA PACIFIC: APTAMERS MARKET FOR RESEARCH & DEVELOPMENT,
BY COUNTRY, 2019–2026 (USD MILLION)
8.4 DIAGNOSTICS
8.4.1 THE INCREASING PREVALENCE OF DISEASES SUCH AS CANCER AND PRODUCT LAUNCHES ARE PROJECTED TO DRIVE THE SEGMENT GROWTH
・ TABLE 38......... APTAMERS MARKET FOR DIAGNOSTICS, BY REGION,
2019–2026 (USD MILLION)
・ TABLE 39. NORTH AMERICA: APTAMERS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 40........ EUROPE: APTAMERS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 41.. ASIA PACIFIC: APTAMERS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION)
8.5 OTHER APPLICATIONS
・ TABLE 42.......... APTAMERS MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION)
・ TABLE 43........... NORTH AMERICA: APTAMERS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 44.. EUROPE: APTAMERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 45................ ASIA PACIFIC: APTAMERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
9.... APTAMERS MARKET, BY END USER
9.1 INTRODUCTION
・ TABLE 46...... APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 PROMINENT PLAYERS OFFERING SERVICES FOR DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
・ TABLE 47................. APTAMERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 48.................... NORTH AMERICA: APTAMERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 49.... EUROPE: APTAMERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 50. ASIA PACIFIC: APTAMERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
9.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
9.3.1 COLLABORATIVE EFFORTS AMONG COMPANIES & RESEARCH INSTITUTES WILL DRIVE THE GROWTH OF THE MARKET
・ TABLE 51....... APTAMERS MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 52... NORTH AMERICA: APTAMERS MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 53.............. EUROPE: APTAMERS MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 54........ ASIA PACIFIC: APTAMERS MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS
9.4.1 RESEARCH PARTNERSHIPS BETWEEN PHARMA PLAYERS AND CONTRACT ORGANIZATIONS DRIVE MARKET GROWTH.. 90
・ TABLE 55... APTAMERS MARKET FOR CROS, BY REGION, 2019–2026 (USD MILLION)
・ TABLE 56........ NORTH AMERICA: APTAMERS MARKET FOR CROS, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 57..... EUROPE: APTAMERS MARKET FOR CROS, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 58............ ASIA PACIFIC: APTAMERS MARKET FOR CROS, BY COUNTRY,
2019–2026 (USD MILLION)
9.5 OTHER END USERS
・ TABLE 59... APTAMERS MARKET FOR OTHER END USERS, BY REGION,
2019–2026 (USD MILLION)
・ TABLE 60..... NORTH AMERICA: APTAMERS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 61.. EUROPE: APTAMERS MARKET FOR OTHER END USERS, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 62 ASIA PACIFIC: APTAMERS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
10.. APTAMERS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
・ FIGURE 29.......... NORTH AMERICA: APTAMERS MARKET SNAPSHOT
・ TABLE 64........ NORTH AMERICA: APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 65..... NORTH AMERICA: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 66... NORTH AMERICA: APTAMERS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 67... NORTH AMERICA: APTAMERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 68....... NORTH AMERICA: APTAMERS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 THE US DOMINATES THE APTAMERS MARKET
・ TABLE 69......... US: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 70.... US: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 71..... US: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 72. US: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 INCREASING GOVERNMENT FUNDING PROMOTES MARKET GROWTH
・ TABLE 73. CANADA: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 74.... CANADA: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 75.... CANADA: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 76. CANADA: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3 EUROPE
・ TABLE 77.. EUROPE: APTAMERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・ TABLE 78.. EUROPE: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 79..... EUROPE: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 80..... EUROPE: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 81.. EUROPE: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 UK
10.3.1.1 COLLABORATIVE EFFORTS FOR APTAMER RESEARCH AND INCREASING INVESTMENT IN APTAMERS TO DRIVE MARKET GROWTH
・ TABLE 82......... UK: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 83.... UK: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 84..... UK: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 85. UK: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 GERMANY HAS REPORTED A SIGNIFICANT INCREASE IN APTAMER-RELATED RESEARCH
・ TABLE 86 GERMANY: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 87............ GERMANY: APTAMERS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 88............ GERMANY: APTAMERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 89 GERMANY: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 RISING INVESTMENT IN APTAMER RESEARCH TO DRIVE THE MARKET GROWTH
・ TABLE 90.. FRANCE: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 91..... FRANCE: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 92..... FRANCE: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 93.. FRANCE: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 GROWTH OF THE LIFE SCIENCE AND PHARMACEUTICAL INDUSTRY TO EXPAND THE MARKET IN ITALY
・ TABLE 94..... ITALY: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 95. ITALY: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 96. ITALY: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 97...... ITALY: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 INCREASED R&D FUNDING IN APTAMER RESEARCH TO MAXIMIZE MARKET GROWTH
・ TABLE 98.... SPAIN: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 99 SPAIN: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 100...... SPAIN: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 101.. SPAIN: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
・ TABLE 102... REST OF EUROPE: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 103. REST OF EUROPE: APTAMERS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 104. REST OF EUROPE: APTAMERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 105..... REST OF EUROPE: APTAMERS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
・ FIGURE 30.............. ASIA PACIFIC: APTAMERS MARKET SNAPSHOT
・ TABLE 106........... ASIA PACIFIC: APTAMERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・ TABLE 107. ASIA PACIFIC: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 108...... ASIA PACIFIC: APTAMERS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 109...... ASIA PACIFIC: APTAMERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 110.......... ASIA PACIFIC: APTAMERS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.4.1 CHINA
・ TABLE 111.. CHINA: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 112..... CHINA: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 113..... CHINA: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 114.. CHINA: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 COLLABORATIVE EFFORTS BY MARKET PLAYERS WILL PROPEL MARKET GROWTH IN JAPAN
・ TABLE 115.. JAPAN: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 116..... JAPAN: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 117..... JAPAN: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 118.. JAPAN: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 GOVERNMENT INITIATIVES AND INCREASED DISEASE BURDEN TO BOOST THE MARKET GROWTH
・ TABLE 119... INDIA: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 120 INDIA: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 121 INDIA: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 122... INDIA: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.4 ROAPAC
・ TABLE 123 ROAPAC: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 124... ROAPAC: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 125... ROAPAC: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 126 ROAPAC: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 INCREASE IN R&D EXPENDITURE TO SUPPORT THE MARKET GROWTH
・ TABLE 127..... LATIN AMERICA: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 128... LATIN AMERICA: APTAMERS MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION)
・ TABLE 129... LATIN AMERICA: APTAMERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION)
・ TABLE 130....... LATIN AMERICA: APTAMERS MARKET, BY END USER,
2019–2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 APTAMER RESEARCH AND INCREASING BURDEN OF CANCER TO PROMOTE MARKET GROWTH
・ TABLE 131............. LUNG CANCER EPIDEMIOLOGY IN MIDDLE EAST COUNTRIES IN 2018
・ TABLE 132..... MEA: APTAMERS MARKET, BY TYPE, 2019–2026 (USD MILLION)
・ TABLE 133 MEA: APTAMERS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
・ TABLE 134. MEA: APTAMERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・ TABLE 135..... MEA: APTAMERS MARKET, BY END USER, 2019–2026 (USD MILLION)
11.. COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
・ FIGURE 31................. APTAMERS MARKET: STRATEGIES ADOPTED
11.3 MARKET RANKING ANALYSIS
・ FIGURE 32 APTAMERS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2020
11.4 COMPANY EVALUATION MATRIX
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
・ FIGURE 33..... APTAMERS MARKET: COMPANY EVALUATION MATRIX, 2020
11.5 COMPETITIVE BENCHMARKING
11.5.1 COMPANY FOOTPRINT (10 COMPANIES)
・ FIGURE 34. COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE APTAMERS MARKET
11.5.2 COMPANY PRODUCT & SERVICE FOOTPRINT (10 COMPANIES)
・ TABLE 136......... PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE APTAMERS MARKET
11.5.3 COMPANY TECHNOLOGY FOOTPRINT (10 COMPANIES)
・ TABLE 137... TECHNOLOGY FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE APTAMERS MARKET
11.5.4 COMPANY APPLICATION FOOTPRINT (10 COMPANIES)
・ TABLE 138... APPLICATION FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE APTAMERS MARKET
11.5.5 COMPANY END-USER FOOTPRINT (10 COMPANIES)
・ TABLE 139. END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE APTAMERS MARKET
11.6 COMPETITIVE SCENARIO AND TRENDS
11.6.1 PRODUCT & SERVICE LAUNCHES
・ TABLE 140.... APTAMERS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2019–AUGUST 2021
11.6.2 DEALS
・ TABLE 141..... APTAMERS MARKET: DEALS, JANUARY 2017–AUGUST 2021
12.. COMPANY PROFILES
12.1 KEY COMPANIES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
12.1.1 APTAMER GROUP
・ TABLE 142...................... APTAMER GROUP: BUSINESS OVERVIEW
・ TABLE 143......... APTAMER GROUP: PRODUCT/SERVICE OFFERINGS
・ TABLE 144......................................... APTAMER GROUP: DEALS
12.1.2 RAPTAMER DISCOVERY GROUP
・ TABLE 145.... RAPTAMER DISCOVERY GROUP: BUSINESS OVERVIEW
・ TABLE 146.... RAPTAMER DISCOVERY GROUP: PRODUCT OFFERINGS
12.1.3 SOMALOGIC, INC. 145
・ TABLE 147...................... SOMALOGIC, INC.: BUSINESS OVERVIEW
・ TABLE 148..................... SOMALOGIC, INC.: PRODUCT OFFERINGS
・ TABLE 149...................... SOMALOGIC, INC.: PRODUCT LAUNCHES
・ TABLE 150......................................... SOMALOGIC, INC.: DEALS
・ TABLE 151................... SOMALOGIC, INC.: OTHER DEVELOPMENTS
12.1.4 APTAMER SCIENCES, INC.
・ TABLE 152........... APTAMER SCIENCES, INC.: BUSINESS OVERVIEW
・ FIGURE 35.......... APTAMER SCIENCES, INC.: COMPANY SNAPSHOT
・ TABLE 153............. APTAMER SCIENCES, INC.: PRODUCT/SERVICE OFFERINGS
・ TABLE 154.......... APTAMER SCIENCES, INC.: PRODUCT APPROVALS
・ TABLE 155............................... APTAMER SCIENCES, INC.: DEALS
12.1.5 APTAGEN, LLC
・ TABLE 156.......................... APTAGEN, LLC: BUSINESS OVERVIEW
・ TABLE 157............. APTAGEN, LLC: PRODUCT/SERVICE OFFERINGS
・ TABLE 158.............................................. APTAGEN, LLC: DEALS
12.1.6 MARAVAI LIFESCIENCES
・ TABLE 159............. MARAVAI LIFESCIENCES: BUSINESS OVERVIEW
・ FIGURE 36............. MARAVAI LIFESCIENCES: COMPANY SNAPSHOT
・ TABLE 160.............. MARAVAI LIFESCIENCES: SERVICE OFFERINGS
12.1.7 KANEKA CORPORATION
・ TABLE 161.............. KANEKA CORPORATION: BUSINESS OVERVIEW
・ FIGURE 37.............. KANEKA CORPORATION: COMPANY SNAPSHOT
・ TABLE 162............... KANEKA CORPORATION: SERVICE OFFERINGS
12.1.8 NEOVENTURES BIOTECHNOLOGY INC.
・ TABLE 163........... NEOVENTURES BIOTECHNOLOGY INC.: BUSINESS OVERVIEW
・ TABLE 164......................... NEOVENTURES BIOTECHNOLOGY INC.: PRODUCT/SERVICE OFFERINGS
12.1.9 APTUS BIOTECH
・ TABLE 165........................ APTUS BIOTECH: BUSINESS OVERVIEW
・ TABLE 166........... APTUS BIOTECH: PRODUCT/SERVICE OFFERINGS
12.1.10 BASE PAIR BIOTECHNOLOGIES
・ TABLE 167..... BASE PAIR BIOTECHNOLOGIES: BUSINESS OVERVIEW
・ TABLE 168....... BASE PAIR BIOTECHNOLOGIES: PRODUCT/SERVICE OFFERINGS
・ TABLE 169.. BASE PAIR BIOTECHNOLOGIES: OTHER DEVELOPMENTS
12.1.11 AMSBIO
・ TABLE 170.................................. AMSBIO: BUSINESS OVERVIEW
・ TABLE 171.................... AMSBIO: PRODUCT/SERVICE OFFERINGS
12.1.12 NOVAPTECH
・ TABLE 172............................. NOVAPTECH: BUSINESS OVERVIEW
・ TABLE 173.............................. NOVAPTECH: SERVICE OFFERINGS
・ TABLE 174................................................ NOVAPTECH: DEALS.. 164
12.1.13 BIO-TECHNE
・ TABLE 175............................. BIO-TECHNE: BUSINESS OVERVIEW
・ FIGURE 38............................ BIO-TECHNE: COMPANY SNAPSHOT
・ TABLE 176............................ BIO-TECHNE: PRODUCT OFFERINGS
12.1.14 APTITUDE MEDICAL SYSTEMS
・ TABLE 177....... APTITUDE MEDICAL SYSTEMS: BUSINESS OVERVIEW
・ TABLE 178...... APTITUDE MEDICAL SYSTEMS: PRODUCT OFFERINGS
・ TABLE 179.......................... APTITUDE MEDICAL SYSTEMS: DEALS
12.1.15 RAYBIOTECH, INC.
・ TABLE 180..................... RAYBIOTECH, INC.: BUSINESS OVERVIEW
・ TABLE 181........ RAYBIOTECH, INC.: PRODUCT/SERVICE OFFERINGS
12.1.16 ALPHA DIAGNOSTIC INTERNATIONAL, INC.
・ TABLE 182..... ALPHA DIAGNOSTIC INTERNATIONAL, INC.: BUSINESS OVERVIEW
・ TABLE 183...... ALPHA DIAGNOSTIC INTERNATIONAL, INC.: PRODUCT OFFERINGS
12.1.17 CREATIVE BIOLABS
・ TABLE 184.................... CREATIVE BIOLABS: BUSINESS OVERVIEW
・ TABLE 185...... CREATIVE BIOLABS: PRODUCT/SERVICE OFFERINGS
12.1.18 CREATIVE BIOGENE
・ TABLE 186.................... CREATIVE BIOGENE: BUSINESS OVERVIEW
・ TABLE 187...... CREATIVE BIOGENE: PRODUCT/SERVICE OFFERINGS
12.1.19 VIVONICS INC.
・ TABLE 188........................... VIVONICS INC: BUSINESS OVERVIEW
・ TABLE 189............. VIVONICS INC: PRODUCT/SERVICE OFFERINGS
12.1.20 IBA LIFESCIENCES GMBH
・ TABLE 190............ IBA LIFESCIENCES GMBH: BUSINESS OVERVIEW
・ TABLE 191.............. IBA LIFESCIENCES GMBH: PRODUCT/SERVICE OFFERINGS
12.2 OTHER PLAYERS
12.2.1 APTABHARAT INNOVATIONS PVT. LTD
・ TABLE 192......... APTABHARAT INNOVATIONS: COMPANY OVERVIEW
12.2.2 PROFACGEN
・ TABLE 193............................. PROFACGEN: COMPANY OVERVIEW
12.2.3 MEDIVEN
・ TABLE 194................................. MEDIVEN: COMPANY OVERVIEW
12.2.4 PURE BIOLOGICS SA.. 176
・ TABLE 195.................. PURE BIOLOGICS SA: COMPANY OVERVIEW
12.2.5 OAK BIOSCIENCES, INC.
・ TABLE 196 OAK BIOSCIENCES, INC.: COMPANY OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13.. APPENDIX